Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
New Insights on CAB Gel Performance Across Diverse Acne Demographics This is a must-read article from the Journal of Drugs in Dermatology (JDD) that every practicing clinician will want on…
From the Vault: Uncovering the Broader Systemic and Cardiovascular Benefits of Shingles Immunization While dermatologists routinely counsel patients on preventing the painful cutaneous and neurological sequelae of herpes zoster, the…
Evaluating Dietary Strategies as Adjunctive Interventions in Inflammatory Skin Disease As patients increasingly seek non-pharmacologic interventions to support their psoriasis treatment, interest in dietary modifications has surged. However, clinical guidance…
From JDD's Vault: The State of Sunscreens in the US: Caveat Emptor With the FDA’s groundbreaking June 2026 approval of a new sunscreen ingredient, bemotrizinol (also called BEMT or Tinosorb…
Beyond the Skin: Navigating Psoriasis Treatment and Patient Burden Management of psoriasis can often involve trialing several medications, extensive patient counseling, and working with insurance companies to get the optimal…
New Data on Acne Linked to Oral JAK Inhibitors: What Dermatology Clinicians Should Know Have you read this article from the JDD? Acne is emerging as a notable cutaneous adverse…